The U.S. antitrust regulator asked Biogen Inc. to present documents related to the approval and marketing of the company’s Alzheimer’s disease treatment, the drugmaker disclosed in a filing.
Eli Lilly said on May 27 the company received a subpoena from the U.S. Department of Justice related to the New Jersey plant that makes the Covid-19 treatment, bamlanivimab.
The U.S. House Oversight Committee decided to subpoena AbbVie Inc. to seek documents on the drugmaker’s blockbuster treatments, Humira and Imbruvica, as part of an investigation into drug pricing practices.
Johnson & Johnson Chief Executive Alex Gorsky told a jury Monday that he did not read all the internal company documents related to potential asbestos contamination in Johnson’s Baby Powder.
Federal prosecutors are investigating six pharmaceutical companies for potential criminal charges in connection with shipping large quantities of opioid painkillers that contributed to a healthcare crisis, according to regulatory filings.
Congressional Democrats threatened to subpoena Juul Labs if the e-cigarette maker does not provide documents relating to the company’s products and marketing practices, as a House panel looks into whether Juul deliberately targeted children.
Johnson & Johnson received subpoenas from the U.S. Justice Department and the Securities and Exchange Commission related to litigation involving alleged asbestos contamination in the company’s signature Baby Powder product line.
Britain’s Indivior was subpoenaed by the California Department of Insurance over its blockbuster opioid addiction treatment Suboxone Film, which is rapidly losing market share due to stiff competition from generic versions.
Endo International received a grand jury subpoena from federal prosecutors in Miami seeking documents related to drugs it produces that contain oxymorphone.
Ocular Therapeutix Inc. said the U.S. Securities and Exchange Commission (SEC) issued a subpoena seeking information about the company’s eye-pain drug Dextenza.